We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

ThromboGenics Announces Publication of New England Journal of Medicine Paper

News   Sep 15, 2012

 
ThromboGenics Announces Publication of New England Journal of Medicine Paper
 
 
 

RELATED ARTICLES

Novel Drug May Reverse Breast Cancer Hormone Therapy Resistance

News

A novel drug based on a natural compound found in cruciferous vegetables could hold the key to reversing resistance to breast cancer hormone therapy, according to new research.

READ MORE

Gene Therapy for Duchenne Muscular Dystrophy Successful in Pigs

News

An interdisciplinary Munich research team led by scientists from TUM has for the first time succeeded in correcting the mutated dystrophin gene in living pigs. In order to cut the defective gene sequence from the DNA of the animals' muscle and heart cells, the researchers modified the Crispr-Cas9 gene scissors.

READ MORE

Gene Therapy for Life-limiting Blood Disorder Becomes Commercially Available

News

bluebird bio Inc. have announced that their gene therapy for the blood disorder transfusion-dependent β-thalassemia (TDT) is commercially available for the first time.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE